THE UNITED REPUBLIC OF TANZANIA
MINISTRY OF HEALTH
KIBONG'OTO INFECTIOUS DISEASES HOSPITAL
Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs (pulmonary TB) but can also affect other parts of the body such as the lymph nodes, spine, brain, and kidneys (extrapulmonary TB). TB remains a major public health concern in Tanzania and globally.
At Kibong’oto Infectious Disease Hospital (KIDH), specialized diagnosis, treatment, and management of drug-sensitive and drug-resistant TB are provided
Close contact with a person who has active TB
HIV infection
Weak immune system
Malnutrition
Diabetes
Overcrowded living conditions
Smoking and substance abuse
TB is caused by the bacterium Mycobacterium tuberculosis. It spreads from person to person through the air when someone with active TB of the lungs coughs, sneezes, speaks, or sings.
Coughing up blood
Fever
Night sweats
Weight loss
Fatigue
At KIDH, TB is diagnosed using advanced laboratory technologies including:
Sputum smear microscopy
GeneXpert MTB/RIF testing
TB culture and drug susceptibility testing
Chest X-ray
Molecular diagnostic techniques (for drug resistance detection)
TB is treatable and curable.
Drug-sensitive TB is treated with a combination of antibiotics for 6 months.
Drug-resistant TB requires longer treatment with specialized second-line medicines.
Treatment adherence is critical to prevent resistance.
Patients receive comprehensive clinical monitoring and support services at KIDH.
Early testing and prompt treatment
Proper ventilation in homes and workplaces
Wearing masks in high-risk settings
TB preventive therapy for high-risk individuals
Infection prevention and control measures
BCG vaccination in children
